Showing results (51-60 of 802) with videos related to
Sort By:
Pageof 81
The Journal of Pharmacology and Experimental Therapeutics|November 30, 2012
Impact of tumor blood flow modulation on tumor sensitivity to the bioreductive drug banoxantroneEugene Manley, David J WaxmanMolecular Cancer Therapeutics|May 3, 2013
Impact of tumor vascularity on responsiveness to antiangiogenesis in a prostate cancer stem cell-derived tumor modelKexiong Zhang, David J WaxmanMolecular Pharmacology|April 19, 2002
Post-transcriptional regulation of hepatic NADPH-cytochrome P450 reductase by thyroid hormone: independent effects on poly(A) tail length and mRNA stabilityDongxu Liu, David J WaxmanCancer Gene Therapy|August 11, 2001
Modulation of cyclophosphamide-based cytochrome P450 gene therapy using liver P450 inhibitorsZ Huang, D J WaxmanThe Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistanceG Chen, D J WaxmanReproductive Toxicology (Elmsford, N.Y.)|June 2, 2015
Early programing of uterine tissue by bisphenol A: Critical evaluation of evidence from animal exposure studiesAlexander Suvorov, David J WaxmanMolecular Pharmacology|October 7, 2004
Antitumor activity of methoxymorpholinyl doxorubicin: potentiation by cytochrome P450 3A metabolismHong Lu, David J WaxmanThe Journal of Biological Chemistry|September 13, 2005
Role of the cytokine-induced SH2 domain-containing protein CIS in growth hormone receptor internalizationTanya Landsman, David J WaxmanInternational Journal of Andrology|January 9, 2008
Toxicity of ethylene glycol monomethyl ether: impact on testicular gene expressionGargi Bagchi, David J WaxmanPageof 81